Key result
In stable CAD patients undergoing PCI, having multiple chronic total occlusions was associated with higher all-cause mortality compared to a single occlusion (p=0.037).
Why the study?
Data comparing long-term outcomes after PCI in stable CAD patients with single versus multiple CTOs were scarce.
Does the presence of multiple CTOs worsen long-term mortality compared to a single CTO in stable CAD patients undergoing PCI?
Cohort (n=670)
No
Does the presence of multiple CTOs worsen long-term mortality compared to a single CTO in stable CAD patients undergoing PCI?
In stable CAD patients undergoing CTO-PCI, the presence of multiple CTOs is an independent predictor of long-term cardiac mortality.
BACKGROUND: Rapid advancements in percutaneous coronary intervention (PCI) have improved the outcome of chronic coronary total occlusions (CTOs); however, data regarding the difference in long-term outcomes in stable coronary artery disease (CAD) patients with single and multiple CTOs who underwent PCI are scarce. This study aimed to compare the long-term outcomes of patients with multiple CTOs and single CTO after PCI. METHODS: This study cohort included stable CAD patients who were diagnosed with CTO and treated with PCI from a single center. The primary endpoint was all-cause death. RESULTS: We retrospectively reviewed 670 consecutive patients with CTO-PCI. Among them, 539 patients had a single CTO, and 131 (19.7%) patients had multiple (at least two) CTOs. CTO revascularization was achieved in 470 (70.1%) patients. After a median follow-up duration of 33.7 months, the cumulative all-cause mortality (p = 0.037) and cardiac mortality (p = 0.003) were higher in patients with multiple CTOs than in those with a single CTO. In the multivariable model, multiple CTOs and left ventricular ejection fraction (LVEF) less than 40% were independent predictors for cardiac death (adjusted hazard ratio (HR) 2.53; P = 0.013 and adjusted HR 3.95; P < 0.001), while age older than 65 and LVEF less than 40% were independent predictors for all-cause death in CTO-PCI patients (adjusted hazard ratio (HR) 1.84; P = 0.035 and adjusted HR 2.54; P = 0.001). CONCLUSION: In CTO-PCI patients, long-term survival was associated with multiple CTOs, age and LVEF, but not with CTO revascularization.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cohort in Stable coronary artery disease with chronic total occlusion (n=670). Multiple chronic total occlusions (CTOs) vs. Single CTO was evaluated on all-cause death (p=0.037). In stable CAD patients undergoing PCI, having multiple chronic total occlusions was associated with higher all-cause mortality compared to a single occlusion (p=0.037).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: